Gout
Gout is an inborn error of purine metabolism characterized by
- Hyperuricemia
- Recurrent episodes of acute arthritis
Definition
- Gout is a crystal deposition arthropathy associated with the presence of sodium monourate crystals within the neutrophils of synovial fluid associated with an inflammatory arthropathy
- Derived from Latin “Gutta” = ”a drop” which means a manevolent humor dropping into weakened joints
- Diagnosis confirmed by crystals of Monosodium Urate in synovial fluid
- Other features
- Tophi ("Porous stone") = urate in soft tissues
- Renal urate stones
Epidemiology
- Adult men
- M:F – 20:1
- Peak 40-60 years
- Family History
Physiology
- Prerequisite is hyperuricaemia at some stage
- Uric acid level determined by balance between production & excretion
- Production
- Produced by breakdown of nucleic acids
- By oxidation of Purine bases (Guanine & Adenine)
- Converted Inosine » Hypoxanthine » Xanthine » Uric Acid
- enzyme that allows the production of xanthine is Xanthine Oxidase
- Excretion
- 2/3 excreted into urine
- Uric Acid filtered at glomerulus
- Reabsorbed in PCT
- Secreted in subsequent PCT
- 2/3 excreted into urine
- 1/3 excreted into GIT
Asymptomatic Hyperuricaemia
- Elevated serum urate in absence of sequelae of hyperuricaemia
- Ie. absence of gouty arthritis, renal stones, tophi
- Defined by serum urate levels
- Greater than 7mg/dL in men & postmenopausal women
- 6mg/dL in premenopausal women
- Nil treatment required
Classification
- Primary gout - 95%
- Inheritable disorder (usually idiopathic)
- Overproducers ~ 10%
- Underexcretors ~ 90%
- Inheritable disorder (usually idiopathic)
- Secondary gout - 5%
- Acquired disorder
- Also caused by excessive purine load or underexcretion
- Acquired disorder
- Primary gout 95%
- Hyperuricaemia due to inheritable error of metabolism
- Overproducers ~ 10%
- Due to disturbance of purine biosynthesis
- Defined as producing more than 600mg of uric acid per 24 hours after 5 days of dietary purine restriction
- Due to disturbance of purine biosynthesis
- Most of the conditions are polygenic or X-linked in nature
- Usually idiopathic
- Some specific enzyme defects known
- Hypoxanthineguanine phosphoribosyl transferase deficiency (HGPRT)
- Lesch-Nylan Syndrome
- Hypoxanthineguanine phosphoribosyl transferase deficiency (HGPRT)
- Phosphoribosyl Pyrophosphate Synthetase overactivity
- Increased production of Ribose-5-phosphate
- Underexcretors ~ 90%
- Make up the majority of the patients with primary gout
- Due to abnormal renal excretion of uric acid
- Generally they eliminate less than 350mg of uric acid per 24 hours
- Renal excretion dependent on
- GFR
- Tubular resorption
- Tubular secretion
- Any one of these three or all can be implicated
- Secondary Gout 5%
- Due to other acquired disorders
- Overproduction or Underexcretion
- Causes include
- Ingestion of foods high in purine
- High cell death/ DNA breakdown
- Myeloproliferative disease following chemotherapy
- Chronic haemolysis
- Drugs that ↑ tubular resorption of uric acid
- Diuretics
- Salicylates
- Renal failure
- Acidosis
- Ketoacidosis (starvation)
- Lactic acidosis
- Acute alcoholism
- Obesity
*Lesch-Nyhan Syndrome
- Rare
- X-linked Recessive
- Absence of enzyme in purine pathway
- Leads to excessive uric acid formation & gout
- Young boys
- Retardation
- Self-mutilation
Pathogenesis
Acute Gouty Arthritis
- Sustained hyperuricaemia
- Develop monosodium urate monohydrate deposits in synovial lining cells & in cartilage on proteoglycans which are inert
- Subsequently released into synovial fluid & connective tissue
- Precipitates at > 8mg/dL
- Due to
- Proteoglycan turnover
- Trauma
- Low pH
- Unequal resorption of water & urate from synovial fluid
- Sufficient number of crystals in joint precipitates acute inflammation
- Crystals cause an inflammatory response
- Rapid ↑ in PMN
- Phagocytosis of crystals
- Cells then degraded due to failure of metabolism of the crystals
- Subsequent release of the lysosomal enzymes & toxic substances
- Proteases incl Collagenase
- Free radicals
- PG
- Leukotriene
- Activate complement & platelets
- Disrupt lysosomes in leukocytes with cell rupture
Chronic Gouty Arthritis
- Tophi (Greek = “chalk stone”) of Monosodium Urate Monohydrate Crystal
- Composed of nodular core of monosodium urate crystals with surrounding granulomatous reaction with foreign body giant cells
- Very similar to rheumatoid nodules
- Aggregates deposited in synovium, cartilage & tendon sheaths
- Leads to cartilage destruction & periarticular cyst formation
- May ulcerate through the skin
Clinical Features
- "Obese, rubicund, hypertensive & fond of alcohol"
- 4 stages
- Initial asymptomatic hyperuricaemia
- First attack of Acute Gouty Arthritis
- When this settles, hyperuricaemia persists
- Recurrent attacks
- Frequency of attacks varies, may increase
- Chronic Gouty Arthritis develops
- With joints no longer recovering from acute attacks
- Arthritis & tophi develop
- Hyperuricaemia
- In men begins at puberty
- In women starts at menopause
- Only 5% of hyperuricaemic patients develop gout
- Risk of Gout ↑ with
- Serum Urate Level
- Duration of hyperuricaemia
- Usually develops after 20-30 years
- Acute Gouty Arthritis
- Predominantly affects distal LL
- 70% initially 1st MTPJ (Podagra)
- Predominantly affects distal LL
- May also involve
- Other joints in foot
- AJ
- Knee
- Elbow
- Hands
- Usually monoarticular
- Rapid onset
- Excruciating night pain
- Hot red shiny swollen joint
- Very painful to touch
- May have systemic features
- Fever
- Leukocytosis
- Raised ESR
- Takes days/ weeks to resolve
- Pain-free intervals of variable length
- Onset may be spontaneous or
- May be precipitated by
- Excessive activity
- Trauma
- Diet excess
- Alcohol consumption
- Diuretics
- Systemic illness or infection
- Surgery
- Chronic Gouty Arthritis
- Arthritis
- After repeated attacks of gout
- 17% get chronic tophaceous gout 3-14 years after initial attack
- Degree & duration of hyperuricemia reflects rate of crystal deposition
- After repeated attacks of gout
- Arthritis
- Asymmetrical destructive arthropathy
- Articular erosions
- Deformity
- Often involves small joints in hand
- Tophi
- In 20% of cases
- White mass of sodium urate crystals
- Visible underlying thinned-out skin
- May necrose overlying skin & discharge
- Involve
- Synovium
- Subchondral bone
- Periarticular subcutaneous tissue
- Olecranon, Archilles, & Prepatellar bursae
- Helix of ear (actually uncommon)
- Renal Stones
- 15% of cases
- Radiolucent uric acid stones
- Secondary CRF
Investigations
Laboratory Tests
- Leucocytosis, elevated ESR & CRP may be seen
- Serum Uric Acid
- Attacks of gout occur when levels of Serum Uric Acid changes
- Not necessary to have ↑ level during acute attack
- Elevated urate in patient with painful joint not diagnostic of gout
- Attacks of gout occur when levels of Serum Uric Acid changes
- Elevated Serum Urate should be estimated in inter-critical period
- Synovial fluid
- Specimen must be anticoagulated
- Monosodium Urate crystals diagnostic if found in synovial fluid
- Needle-shaped, yellow crystals 10um long
- Lying free or in neutrophils
- Negative birefringent*
- Under polarized light & 1st order red compensator
- Bright yellow when parallel to compensator
- Doesn't exclude another arthropathy
- Especially as infection precipitates urate
- Synovial fluid analysis typically shows
- WCC of 1000-70 000 x 10.6/ L
- With predominantly neutrophils (< 70%)
- *Birefringence
- Positive birefringence
- Blue with crystal parallel to 1st order red compensator & 135° to polarizer
- Yellow with crystal parallel to 1st order red compensator & 45° to polarizer
- Negative birefringence
- Yellow with crystal parallel to 1st order red filter & 135° to polarizer
- Blue with crystal parallel to 1st order red filter & 45° to polarizer
- Positive birefringence
- 24 Hour Urinary Uric Acid Secretion
- 1100mg/day
- 50% chance renal stones
- Hence need Allopurinol
XRay
- Changes with Chronic Gouty Arthritis
- Usually in feet in phalangeal heads
- Characteristic periarticular bony defects
- Punched out lytic appearance
- Overhanging sclerotic margin (Martell’s sign)
- Also joint space narrowing & secondary Osteoarthritis
- No osteopenia as compared with RA
Differential Diagnosis
- Septic arthritis
- Pseudogout
- Acute bursitis
- Cellulitis
- RA
- Osteoarthritis
- Seronegative spondyloarthropathy
Management
Acute Attack
- General
- RICE
- Analgesia
- Often narcotic
- Colchicine
- Inhibits activation of inflammatory mediators by crystals
- Very effective & rapid response strongly diagnostic
- 1mg then 0.5mg q2h
- Continue until
- Patient improves
- Diarrhoea occur
- Maximum 6mg reached
- Continue until
- 80% of patients unable to tolerate optimum dose because of GIT side-effects
- NSAID
- Usually better tolerated than colchicine
- Indomethacin (Indocid) most commonly used
- 50mg tds
- Side effects include
- GIT toxicity
- Sodium retention
- CNS disturbance
- Naproxen & Piroxicam also effective
- Less side effects
- ACTH
- Adrenocorticotrophic Hormone
- Better for acute attack with minimal side effects
- Single 40 IU Intramuscular injection
- Glucocorticoids
- Oral Prednisone where
- Colchicine not tolerated
- NSAID contraindicated (peptic ulcer disease)
- Oral Prednisone where
- Intra-articular steroids may be used
- For severe monoarticular attack
- Especially knee
Prophylaxis
- Likelihood of recurrence can be reduced by
- Weight loss
- Adequate fluid intake
- Avoid precipitating factors
- Alcohol
- Diuretics
- Prophylactic Colchicine 1-2mg/ day
- Antihyperuricaemics
- Absolute indication
- CRF due to stones
- Relative indications
- 3 acute attacks/ year
- Polyarticular gout
- Tophi
- Uric Acid > 500mmol/L
- Absolute indication
- Use drugs that
- Decrease Uric Acid Synthesis
- Allopurinol
- Increase Renal Uric Acid Excretion
- Uricosuric agents
- Probenecid, Sulfapyrazole
- Need good renal function
- No history of renal stone
- Lowers serum urate in 80% patients
- Decrease Uric Acid Synthesis
- Allopurinol
- Inhibits Xanthine Oxidase
- Blocks conversion of Xanthine to uric acid
- 300mg/ day (150mg/ day if CRF)
- Hypersensitivity side effects in 20%
- Rash
- Alopecia
- Marrow suppression
- Hepatitis
- Can be fatal
- Causes ↓ in Serum Urate
- This may precipitate acute attack of gout
- Should not cease when patient already taking Allopurinol
- Alteration to Serum Urate levels can precipitate attack
- Should not cease when patient already taking Allopurinol
- Should not commence treatment with Allopurinol during acute episode
- Initiation should be accompanied by Colchicine or NSAIDS
- Can shrink tophi if keep serum urate < 0.4mmol/ L
Approach
- 3 tier
- 1st Stage
- Weight loss
- Decrease purine intake
- Fluid hydration
- Reverse ↓ GFR
- 2nd Stage
- Indocid
- 50mg tds
- or Colchicine
- 1mg increasing 0.5mg q2h until
- Improved
- Diarrhoea
- Reach 6mg
- 1mg increasing 0.5mg q2h until
- Indocid
- 3rd Stage
- If stones/ tophi/ chronic arthropathy
- Or greater than 3 attacks
- 1st Stage
- Allopurinol
- 300mg od
- Beware hypersensitivity & marrow effects

